Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy.
Vyse
A J
AJ
PHLS Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ, United Kingdom. avyse@phls.org.uk
Gay
N J
NJ
White
J M
JM
Ramsay
M E
ME
Brown
D W G
DW
Cohen
B J
BJ
Hesketh
L M
LM
Morgan-Capner
P
P
Miller
E
E
D000914:Antibodies, Viral / Q000097:blood; D002648:Child; D002675:Child, Preschool; D004739:England / Q000453:epidemiology; D006291:Health Policy; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D008457:Measles / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control; D022542:Measles-Mumps-Rubella Vaccine / Q000008:administration & dosage; D009107:Mumps / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control; D011159:Population Surveillance / Q000379:methods*; D012409:Rubella / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control; D014611:Vaccination / Q000706:statistics & numerical data; D014852:Wales / Q000453:epidemiology
D000914:Antibodies, Viral; D022542:Measles-Mumps-Rubella Vaccine